Terms: = Breast cancer AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF AND Diagnosis
18 results:
1. Delay in the diagnosis and treatment of breast cancer in Vietnam.
Nguyen SM; Nguyen QT; Nguyen LM; Pham AT; Luu HN; Tran HTT; Tran TV; Shu XO
Cancer Med; 2021 Nov; 10(21):7683-7691. PubMed ID: 34664428
[TBL] [Abstract] [Full Text] [Related]
2. Modeling risks of cardiovascular and cancer mortality following a diagnosis of loco-regional breast cancer.
Leoce NM; Jin Z; Kehm RD; Roh JM; Laurent CA; Kushi LH; Terry MB
Breast Cancer Res; 2021 Sep; 23(1):91. PubMed ID: 34579765
[TBL] [Abstract] [Full Text] [Related]
3. Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper.
Ranger TA; Burchardt J; Clift AK; Mei WX; Coupland C; Tan PS; Dixon S; Cardwell CR; Hippisley-Cox J
BMJ Open; 2021 Aug; 11(8):e046701. PubMed ID: 34341043
[TBL] [Abstract] [Full Text] [Related]
4. Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system.
Eaglehouse YL; Georg MW; Shriver CD; Zhu K
Breast Cancer Res Treat; 2019 Nov; 178(2):441-450. PubMed ID: 31414244
[TBL] [Abstract] [Full Text] [Related]
5. A comparison of a brachytherapy and an external beam radiotherapy boost in breast-conserving therapy for breast cancer: local and any recurrences.
Kindts I; Verhoeven K; Laenen A; Christiaens M; Janssen H; Van der Vorst A; Van Limbergen E; Weltens C
Strahlenther Onkol; 2019 Apr; 195(4):310-317. PubMed ID: 30603857
[TBL] [Abstract] [Full Text] [Related]
6. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
[TBL] [Abstract] [Full Text] [Related]
7. Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results.
Burt LM; Ying J; Poppe MM; Suneja G; Gaffney DK
Breast; 2017 Oct; 35():122-129. PubMed ID: 28719811
[TBL] [Abstract] [Full Text] [Related]
8. State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a diagnosis of Invasive Unilateral Early-Stage breast cancer in the United States, 2004-2012.
Nash R; Goodman M; Lin CC; Freedman RA; Dominici LS; Ward K; Jemal A
JAMA Surg; 2017 Jul; 152(7):648-657. PubMed ID: 28355431
[TBL] [Abstract] [Full Text] [Related]
9. Increased risk of salivary gland cancer among women with a previous cancer diagnosis.
Falchook AD; Zevallos JP; Chera BS
Head Neck; 2016 Apr; 38 Suppl 1():E446-51. PubMed ID: 25581457
[TBL] [Abstract] [Full Text] [Related]
10. The role of apparent diffusion coefficient values in the differential diagnosis of breast lesions in diffusion-weighted MRI.
Şahin C; Arıbal E
Diagn Interv Radiol; 2013; 19(6):457-62. PubMed ID: 24004972
[TBL] [Abstract] [Full Text] [Related]
11. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
[TBL] [Abstract] [Full Text] [Related]
12. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
[TBL] [Abstract] [Full Text] [Related]
13. Increased risk of second primary cancers after a diagnosis of melanoma.
Bradford PT; Freedman DM; Goldstein AM; Tucker MA
Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
[TBL] [Abstract] [Full Text] [Related]
14. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
[TBL] [Abstract] [Full Text] [Related]
15. Thyroid cancer and multiple primary tumors in the SEER cancer registries.
Ronckers CM; McCarron P; Ron E
Int J Cancer; 2005 Nov; 117(2):281-8. PubMed ID: 15880372
[TBL] [Abstract] [Full Text] [Related]
16. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
[TBL] [Abstract] [Full Text] [Related]
17. Pregnancy recency and risk of ovarian cancer.
Cooper GS; Schildkraut JM; Whittemore AS; Marchbanks PA
Cancer Causes Control; 1999 Oct; 10(5):397-402. PubMed ID: 10530609
[TBL] [Abstract] [Full Text] [Related]
18. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
Henry-Amar M
Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
[TBL] [Abstract] [Full Text] [Related]
